Statistics for Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study
Total visits
| views | |
|---|---|
| Protocol for a randomised, double-masked, sham-controlled phase 4 study on the efficacy, safety and tolerability of intravitreal aflibercept monotherapy compared with aflibercept with adjunctive photodynamic therapy in polypoidal choroidal vasculopathy: the ATLANTIC study | 351 |
Total visits per month
| views | |
|---|---|
| November 2024 | 4 |
| December 2024 | 4 |
| January 2025 | 0 |
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
File Visits
| views | |
|---|---|
| e015785.full.pdf(legacy) | 393 |
| e015785.full.pdf | 6 |
Top country views
| views | |
|---|---|
| United States | 162 |
| China | 127 |
| Australia | 10 |
| South Korea | 9 |
| Portugal | 9 |
| United Kingdom | 8 |
| Canada | 5 |
| Germany | 4 |
| Brazil | 2 |
| Russia | 2 |
| Ukraine | 2 |
| Argentina | 1 |
| Belgium | 1 |
| Spain | 1 |
| France | 1 |
| Ireland | 1 |
| India | 1 |
| Iran | 1 |
| Japan | 1 |